Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 52 for “"NOD mouse"”.
-
EXERCISE FOR STUDYING TYPE 1 DIABETES IN A NON-OBESE DIABETIC (NOD) MOUSE MODEL
… global health system. The Non-Obese Diabetic (NOD) mouse represents a well-established experimental model analogous to human T1DM as it is characterized by a progressive autoimmune destruction of pancreatic β-cells. This thesis explored the uses of a mouse motorized treadmill to study the …
-
Cornus officinalis extract activates the Keap1/Nrf2 pathway and delays T1D onset in the NOD mouse
… in which we treated the non-obese diabetic mouse (NOD) with an oral gavage of CO. We found that CO significantly delayed T1D onset, hyperglycemia, pancreatic insulitis and preserved c-peptide secretion indicating a preservation of β cell mass and function. Individual composition analysis was …
-
THE ROLE OF EARLY LIFE COMMENSALS & PERIPHERAL REGULATORY T CELLS IN PREVENTING TYPE 1 DIABETES IN THE NOD MOUSE MODEL
… an MHC-II I-E transgene in non-obese diabetic (NOD) mice, a spontaneous mouse model of T1D. I also investigated the effects of a diabetes preventing microbe, Akkermansia muciniphila on immune development and found that it induced peripheral regulatory T cells (Tregs) and strong antibody …
-
Evaluating risks of celiac disease from dietary proteins using gluten sandwich ELISAs, a celiac peptide and protein database, and an ABeta degrees.DQ8.NOD mouse model
… carrying HLA DQ8 haplotype. A transgenic DQ8.NOD mouse model was used to test T cell responses to gluten digests from whole wheat breads made with two Hard Red Winter wheat cultivars, Turkey Red and Expedition, and a commercial Spring wheat. Results indicated that the Turkey Red cultivar was …
-
Type 1 diabetes (T1D) in NOD mouse models : the role of toll-like receptor 7 and an enteric bacterial pathogen in accelerating the development of T1D
… response in T1D. We used non-obese diabetic (NOD) mouse models of human T1D to investigate the role of TLR7 activation and an enteric bacterial pathogen, Citrobacter rodentium, that disrupts the intestinal barrier integrity in the development of T1D. TLR7 activation with the imidazoquinoline …
-
Genome-environment Interactions in Type 1 Diabetes
… type 1 diabetes (T1D) in the non-obese diabetic (NOD) mouse model. Similar to human T1D, disease risk in the NOD mouse is polygenic and has been mapped to multiple Idd loci. We have fine-mapped the Idd4.1 locus and identified Nlrp1b as its candidate gene. We report an alternatively spliced isoform …
-
Use of peptide-MHC II-specific-chimeric antigen receptor Tregs to regulate autoimmunity in type 1 diabetes
… Research using the non-obese diabetic (NOD) mouse model has shown cell therapy with Tregs bearing a transgenic T cell receptor (TCR) specific towards an islet-derived antigen could be superior to prevent and/or reverse T1D. However, limitations of TCR-engineered Tregs include mispairing …
-
MDA5 and a type 1 interferon signature in the development of type 1 diabetes
… in patients onto the non-obese diabetic (NOD) mouse and established its importance in T1D. We describe the first observations that a reduction in MDA5 in the NOD mouse protects from spontaneous and coxsackievirus B4 (CB4)-induced T1D. We also establish the importance of a specific IFN-I …
-
β-Cell Autophagy in the Pathogenesis of Type 1 Diabetes
… as in islets of diabetic non-obese diabetic (NOD) mouse model of autoimmune diabetes. Autophagic flux was also impaired in diabetic NOD mouse islets, further confirming impairment of autophagy. Interestingly, we observed an induction of autophagy after acute treatment with IFN-α both in vitro …
-
Aspects of T cell development contributing to autoimmunity.
… apoptosis resistance in the non-obese diabetic (NOD) mouse. The role of thymic expression of TGF-β was dissected by using TGF-β type II receptor cre/lox conditional knock out mouse model. By transplanting bone marrow to irradiated recipients we restricted the phenotype to hematopoietic stem …
-
The Role of Glucagon-like Peptides in Experimental Type 1 Diabetes
… barrier function, modifies diabetes onset in a mouse model of T1D, the non obese diabetic (NOD) mouse. Although chronic treatment with a long-acting GLP-2 analogue was associated with improved intestinal barrier function, it failed to delay the onset of T1D. Once the autoimmune attack is …
-
Dendritic Cell Regulation of Peripheral Tolerance in Polyclonal T Cell Repertoires
… T cells, thereby preventing autoimmunity in mouse models. We succeeded in inducing tolerance to the myelin oligodendrocyte protein and preventing disease in the experimental autoimmune encephalomyelitis model. However no halt or delay in onset of autoimmune diabetes was observed when insulin …
-
Identifying molecular factors influencing B cells in Type 1 Diabetes
… factors playing a role. The Non-Obese Diabetic (NOD) mouse is used as a model of T1D due to their high susceptibility for this disease, which shares many characteristics with human patients. Research has found that CD4+ and CD8+ T cells are the final mediators of β cell destruction in T1D. …
-
Immune cell function in the Clec16a Knock-down Mouse
… diseases a Clec16a deficient non obese diabetic (NOD) mouse strain was generated by means of lentiviral RNA interference. Clec16a knock down (KD) mice prove to be strongly protected against developing type 1 diabetes, an effect that is mediated by hyporeactive T effector cells. T cell …
-
Macrophage IPLA2ß-Derived Lipid Signaling Contributes to Type 1 Diabetes Development
… spontaneous-T1D prone nonobese diabetic mice (NOD) are high during the pre-diabetic phase. However, the impact of macrophage-derived iDLs in T1D remains unclear. Therefore, we generated a NOD mouse model with a conditional reduction in macrophage iPLA2β, cHET, and cKO mice, to examine the roles …
-
Targeting protein kinase C in an autoimmune diabetes mouse model
… and delay the onset of overt diabetes in the NOD mouse model. A cell permeable, pseudo-substrate peptide inhibitor was shown to inhibit T cell receptor activation, in both in vitro T cell stimulations and ex vivo isolated T cells from treated mice. Pre-diabetic NOD mice treated daily with the …
-
LIPID NANOPARTICLE-MEDIATED DELIVERY OF ENHANCED COSTIMULATION BLOCKADE TO PREVENT TYPE 1 DIABETES
… in spleen, pancreatic and mesenteric lymph nodes. Ex-vivo, Tofa is rapidly delivered by Tofa-NLC to mouse antigen presenting cells preventing their maturation. Short-term administration of Tofa-NLC via oral gavage at early or later stage in NOD mouse can promote a significant reduction of …
-
Revisiting Development and Homeostasis of Thymic Regulatory T Cells in Type 1 Diabetes
… murine models such as the non-obese diabetic (NOD) mouse have suggested that T1D is initiated partly due to either paucity and/or defectiveness of Tregs in the periphery, although other reports contradict this. In contrast Treg development in the thymus is thought to be normal in T1D-prone …
-
The role of interleukin-21 in type-1 diabetes
… (T1D) susceptibility in non-obese diabetic (NOD) mice. Recent studies demonstrate that IL-21 is necessary for the development of autoimmune disease in several models including T1D in NOD mice. This study explores the critical role of IL-21 in the pathogenesis of T1D. In this study, we …
-
Development of Methacrylic Acid Biomaterial-based Therapeutic Tissues for Type 1 Diabetes
… for immunomodulation in the autoimmune diabetic NOD mouse model. MAA-PEG recruited an alternative host response in the subcutaneous space that worked together with added vitamin D3-derived tolerogenic dendritic cells (VDDCs) to effect enhanced immunomodulation (e.g., Treg expansion) locally and …
Page 1 of 3